Skip to main content
. 2016 Feb 16;7(13):15840–15853. doi: 10.18632/oncotarget.7417

Table 4. miR-486-5p expression and clinicopathologic features in patients with gastric carcinoma.

Characteristics miR-486-5p Low/unchanged expression (n=57) miR-486-5p High expression (n=27) Significance
χ2 or Fisher's exact test P-value
Age(years) 4.673 0.031
<60 14(24.6) 13(48.1)
≥60 43(75.4) 14(51.9)
Gender 1.117 0.291
Male 46(80.7) 19(70.4)
Female 11(19.3) 8(29.6)
Local invasion 2.912 0.088
T1+T2 5 (8.8) 6 (22.2)
T3+T4 52 (91.2) 21 (77.8)
Site 1.625 0.202
gastric cardia 13 (22.8) 3(11.1)
non-cardia 44 (77.2) 24(88.9)
TNM stage 0.455 0.5
I + II 23 (40.3) 13 (48.1)
III + IV 34 (59.7) 14 (51.9)
Nodal status 2.422 0.120
positive 45(78.9) 17(63.0)
negative 12(21.1) 10(37.0)
Distant metastasis 0.591
M0 55(96.5) 25(92.6)
M1 2(3.5) 2(7.4)
Tumor size (cm) 1.0
≥10 9(15.8) 4(14.8)
<10 48(84.2) 23(85.2)
Depth of tumor invasion Mucosa, submucosa, muscularis propria, subserosa Penetration of serosa, adjacent structures 40(70.2) 20(74.1) 0.712
17(29.8) 7(25.9) 0.136